Evidence map

ReviewCells2025

Aptamer-ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy.

Bei Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40422200